2m 2m 2m 2m 2m 2m 2m
Galmed Pharmaceu (GLMD)
NASDAQ
$0.70+$0.005 (+0.71%)
Price as of Jun 03, 2026 6:25 PM EDT- $8.4MMarket Cap
- -53.30%1-Year Change
- BiotechnologyIndustry
Galmed Pharmaceu (GLMD)
$0.70+$0.005 (+0.71%)
GLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.69 | ||
Change | -$0.04 (-4.96%) | ||
Open | $0.74 | ||
High | $0.76 | ||
Low | $0.69 | ||
Previous Close | $0.73 | ||
Volume | 153,631 | ||
30-Day Average Volume | 148,900 | ||
1-Week Change | 9.70% | ||
1-Month Change | 21.01% | ||
1-Year Change | -53.30% | ||
3-Year Change | -98.78% | ||
5-Year Change | -99.85% | ||
Fundamentals | |||
Shares Outstanding | 11.1M | ||
Total Assets | $18.6M | ||
Market Cap | $8.4M | ||
Enterprise Value | $4.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 08/30/2024 | ||
Earnings & Revenue